Tumor marker workshops

Tumor Biology

Volumn 24, Issue 4, 2003, Pages 165-171

  Rye, P D ^a   Nustad, K ^a   Stigbrand, T ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

AFP; ALP; Antibody; CA 125; CEA; Cytokeratins; hCG; ISOBM workshops; MUC1; PSA; S100; SCC; Sialyl Lewis; Tumor markers

Indexed keywords

ALKALINE PHOSPHATASE; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CYTOKERATIN; EPITOPE; MONOCLONAL ANTIBODY; MUCIN 1; PROSTATE SPECIFIC ANTIGEN; SIALYL LEWIS X ANTIGEN; TUMOR MARKER;

ANTIGENIC VARIATION; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 0344628754     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074423     Document Type: Conference Paper

References (29)

1. Yin BW, Lloyd KO: Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16. J Biol Chem 2001; 276:27371-27375.
2. O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L: The CA 125 gene: An extracellular superstructure dominated by repeat sequences. Tumor Biol 2001;22:348-366.
3. Yin BW, Dnistrian A, Lloyd KO: Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer 2002;98:737-740.
4. O'Brien TJ, Beard JB, Underwood LJ, Shigemasa K: The CA 125 gene: A newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumor Biol 2002;23/3:154-169.
5. Nustad K, Lebedin Y, Lloyd KO, Shigemasa K, de Bruijn HWA, Jansson B, Nilsson O, Olsen KH, O'Brien TJ: Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Tumor Biol 2002; 23:303-314.
6. Nustad K, Bast RC Jr, Brien TJ, Nilsson O, Seguin P, Suresh MR, Saga T, Nozawa S, Bormer OP, de Bruijn HW, Nap M, Vitali A, Gadnell M, Clark J, Shigemasa K, Karlsson B, Kreutz FT, Jette D, Sakahara H, Endo K, Paus E, Warren D, Hammarström S, Kenemans P, Hilgers J: Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: First report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumor Biol 1996;17/4: 196-219.
7. Nap M, Vitali A, Nustad K, Bast RC Jr, O'Brien TJ, Nilsson O, Seguin P, Suresh MR, Bormer OP, Saga T, de Bruijn HW, Nozawa S, Kreutz FT, Jette D, Sakahara H, Gadnell M, Endo K, Barlow EH, Warren D, Paus E, Hammarström S, Kenemans P, Hilgers J: Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumor Biol 1996;17:325-331.
8. Alpert E, Abelev GI: Summary report: Epitope analysis of human alpha-fetoprotein. Tumor Biol 1998;19:290-292.
9. Kang Y, Matsuura E, Sakamoto T, Sakai M, Nishi S: Analysis of epitopes of mouse monoclonal antibodies against human alpha-fetoprotein. Tumor Biol 2001;22/4:254-261.
10. Karamova ER, Yazova AK, Yakimenko EF, Gussev AI, Abelev GI: New approaches for the detection and characterization of alpha-fetoprotein epitope variants. Tumor Biol 2003;24/1:1-8.
11. Noda K, Miyoshi E, Kitada T, Nakahara S, Gao CX, Honke K, Shiratori Y, Moriwaki H, Sasaki Y, Kasahara A, Hori M, Hayashi N, Taniguchi N: The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: Activation of alpha1-6 fucosyltransferase. Tumor Biol 2002;23/4: 202-211.
12. Stenman U-H, Paus E, Allard WJ, Andersson I, Andrés C, Barnett TR, Becker C, Belenky A, Bellanger L, Pellegrino CM, Børmer OP, Davis G, Dowell B, Grauer LS, Jette DC, Karlsson B, Kreutz FT, van der Kwast TM, Lauren L, Leinimaa M, Leinonen J, Lilja H, Linton HJ, Nap M, Nilsson O, Ng PC, Nustad K, Peter A, Pettersson K, Piironen T, Rapp J, Rittenhouse HG, Rye PD, Seguin P, Slota J, Sokoloff RL, Suresh MR, Very DL, Wang TJ, Wigheden I, Wolfert RL, Yeung KK, Zhang W-M, Zhou Z, Hilgers J: Summary report of the TD-3 Workshop: Characterization of 83 antibodies against prostate specific antigen. Tumor Biol 1999;20/S1:1-12.
13. Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J: Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol 1998;19/S1:1-20.
14. Cao Y, Karsten U: Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): Role of epitope masking by glycans. Histochem Cell Biol 2001;115:349-356.
15. Butschak G, Karsten U: Isolation and characterization of Thomsen-Friedenreich-specific antibodies from human serum. Tumor Biol 2002;23/3:113-122.
16. Rye PD, McGuckin MA: MUC1: Antibodies and immunoassays. Tumor Biol 2001;22:269-272.
17. Norum LF, Sauren AM, Rye PD, Nustad K: New Immunoassays for MUC1 in breast cancer. Tumor Biol 2001;22:216-222.
18. Norum LF, Nilsson O, Nustad K: Automated immunofluorometric assays for MUC1. Tumor Biol 2001;22:169-175.
19. Bjerner J, Norum LF, Nilsson O, Nustad K: MUC1 serum assays in breast cancer: Tumor specificities and reference levels. Tumor Biol 2002;23:315-323.
20. Stigbrand T, Andres C, Bellanger L, Bishr Omary M, Bodenmuller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjodin A, Sundstrom B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J: Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: The ISOBM TD5-1 Workshop. Tumor Biol 1998; 19/2:132-152.
21. Stigbrand T: The versatility of cytokeratins as tumor markers. Tumor Biol 2001;22/1:1-3.
22. Miedouge M, Devys A, Simon M, Rouzaud P, Salama G, Reyre J, Pujazon M, Carles P, Serre G: High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients. Tumor Biol 2001;22:19-26.
23. Nap M, van Wel T, Andres C, Bellanger L, Bodenmuller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Meier T, Seguin P, Sjodin A, Stigbrand T, Sundstrom BE, van Dalen A, Wiebelhaus E, Wiklund B, Hilgers J: Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 Workshop. Tumor Biol 2001;22:4-10.
24. Rye PD, Bovin NV, Vlasova EV, Molodyk AA, Baryshnikov A, Kreutz FT, Garinther WI, Schultes BC, Noujaim AA, Madiyalakan R, Magnani J, Nilsson O, Nilsson K, Nustad K, Norum L, Bell H, Cao Y, Suresh MR, Very DL, Freeman JV, Yeung KK, Hilgers J: Summary report on the ISOBM TD-6 Workshop: Analysis of 20 monoclonal antibodies against sialyl Lewisa and related antigens. Tumor Biol 1998; 19;390-420.
25. Berger P, Sturgeon C, Bidart J-M, Paus E, Gerth R, Niang M, Bristow A, Birken S, Stenman UH: The ISOBM TD-7 workshop on hCG and related molecules. Tumor Biol 2002;23:1-38.
26. Hammarström S, Shively JE, Paxton RJ, Beatty BG, Larsson A, Ghosh R, Bormer O, Buchegger F, Mach JP, Burtin P, et al: Antigenic sites in carcinoembryonic antigen. Cancer Res 1989;49:4852-4858.
27. Nap M, Hammarström ML, Bormer O, Hammarström S, Wagener C, Handt S, Schreyer M, Mach JP, Buchegger F, von Kleist S, et al: Specificity and affinity of monoclonal antibodies to carcinoembryonic antigen. Cancer Res 1992; 52:2329-2339.
28. Bjerner P, Lebedin Y, Bellanger L, Kuroki M, Shively JE, Varaas T, Nustad K, Hammarström S, Børmer OP: Protein epitopes in CEA. Tumor Biol 2002;23:249-262.
29. Magnusson P, Ärlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL: Monoclonal antibodies against tissue-nonspecific alkaline phosphatase: Report of the ISOBM TD9 Workshop. Tumor Biol 2002;23:228-248.